Return On Assets in % of AVADEL PHARMACEUTICALS PLC from Q1 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
AVADEL PHARMACEUTICALS PLC quarterly/annual Return On Assets history and change rate from Q1 2014 to Q3 2025.
  • AVADEL PHARMACEUTICALS PLC Return On Assets for the quarter ending 30 Sep 2025 was 11 %.
  • AVADEL PHARMACEUTICALS PLC annual Return On Assets for 2024 was -30.2 %, a 66.6% increase from 2023.
  • AVADEL PHARMACEUTICALS PLC annual Return On Assets for 2023 was -90.4 %, a 8.06% decline from 2022.
  • AVADEL PHARMACEUTICALS PLC annual Return On Assets for 2022 was -83.6 %, a 194% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 11 +55.7 01 Jul 2025 30 Sep 2025
Q2 2025 -1.73 +59.6 +97.2% 01 Apr 2025 30 Jun 2025
Q1 2025 -16.3 +68.9 +80.9% 01 Jan 2025 31 Mar 2025
Q4 2024 -30.2 +60.2 +66.6% 01 Oct 2024 31 Dec 2024
Q3 2024 -44.8 +49.1 +52.3% 01 Jul 2024 30 Sep 2024
Q2 2024 -61.3 +30.8 +33.5% 01 Apr 2024 30 Jun 2024
Q1 2024 -85.2 +13.1 +13.4% 01 Jan 2024 31 Mar 2024
Q4 2023 -90.4 -6.74 -8.06% 01 Oct 2023 31 Dec 2023
Q3 2023 -93.8 -25.3 -36.9% 01 Jul 2023 30 Sep 2023
Q2 2023 -92.1 -31.8 -52.8% 01 Apr 2023 30 Jun 2023
Q1 2023 -98.3 -62.7 -176% 01 Jan 2023 31 Mar 2023
Q4 2022 -83.6 -55.2 -194% 01 Oct 2022 31 Dec 2022
Q3 2022 -68.6 -45.5 -198% 01 Jul 2022 30 Sep 2022
Q2 2022 -60.3 -41.8 -227% 01 Apr 2022 30 Jun 2022
Q1 2022 -35.6 -33.8 -1941% 01 Jan 2022 31 Mar 2022
Q4 2021 -28.5 -30.8 -1303% 01 Oct 2021 31 Dec 2021
Q3 2021 -23 -29.1 -480% 01 Jul 2021 30 Sep 2021
Q2 2021 -18.4 -27 -315% 01 Apr 2021 30 Jun 2021
Q1 2021 -1.74 +10.6 +85.9% 01 Jan 2021 31 Mar 2021
Q4 2020 2.37 +22.9 01 Oct 2020 31 Dec 2020
Q3 2020 6.06 +61.1 01 Jul 2020 30 Sep 2020
Q2 2020 8.6 +59.3 01 Apr 2020 30 Jun 2020
Q1 2020 -12.4 +29 +70.1% 01 Jan 2020 31 Mar 2020
Q4 2019 -20.6 +13.9 +40.3% 01 Oct 2019 31 Dec 2019
Q3 2019 -55.1 -41.5 -305% 01 Jul 2019 30 Sep 2019
Q2 2019 -50.7 -50 -6566% 01 Apr 2019 30 Jun 2019
Q1 2019 -41.4 -52 -492% 01 Jan 2019 31 Mar 2019
Q4 2018 -34.5 -60.5 -232% 01 Oct 2018 31 Dec 2018
Q3 2018 -13.6 -44.8 -143% 01 Jul 2018 30 Sep 2018
Q2 2018 -0.76 -16.4 -105% 01 Apr 2018 30 Jun 2018
Q1 2018 10.6 +14.3 01 Jan 2018 31 Mar 2018
Q4 2017 26 +42.6 01 Oct 2017 31 Dec 2017
Q3 2017 31.2 +19.2 +160% 01 Jul 2017 30 Sep 2017
Q2 2017 15.7 01 Apr 2017 30 Jun 2017
Q1 2017 -3.72 01 Jan 2017 31 Mar 2017
Q4 2016 -16.5 01 Oct 2016 31 Dec 2016
Q3 2016 12 01 Jul 2016 30 Sep 2016
Q2 2015 -24.2 +9.08 +27.3% 01 Apr 2015 30 Jun 2015
Q1 2015 -27 +18.6 +40.8% 01 Jan 2015 31 Mar 2015
Q4 2014 -49.2 01 Oct 2014 31 Dec 2014
Q3 2014 -33.1 01 Jul 2014 30 Sep 2014
Q2 2014 -33.2 01 Apr 2014 30 Jun 2014
Q1 2014 -45.6 01 Jan 2014 31 Mar 2014

AVADEL PHARMACEUTICALS PLC Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -30.2 +60.2 +66.6% 01 Jan 2024 31 Dec 2024
2023 -90.4 -6.74 -8.06% 01 Jan 2023 31 Dec 2023
2022 -83.6 -55.2 -194% 01 Jan 2022 31 Dec 2022
2021 -28.5 -30.8 -1303% 01 Jan 2021 31 Dec 2021
2020 2.37 +22.9 01 Jan 2020 31 Dec 2020
2019 -20.6 +13.9 +40.3% 01 Jan 2019 31 Dec 2019
2018 -34.5 -60.5 -232% 01 Jan 2018 31 Dec 2018
2017 26 +42.6 01 Jan 2017 31 Dec 2017
2016 -16.5 01 Jan 2016 31 Dec 2016
2014 -49.2 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.